156 related articles for article (PubMed ID: 36564282)
1. Transcription factor c-Maf-targeted cancer immunotherapy.
Wang Y; Qiu F; Yan J
Trends Cancer; 2023 Apr; 9(4):265-269. PubMed ID: 36564282
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma.
Cao S; Liu J; Chesi M; Bergsagel PL; Ho IC; Donnelly RP; Ma X
J Immunol; 2002 Nov; 169(10):5715-25. PubMed ID: 12421951
[TBL] [Abstract][Full Text] [Related]
3. c-Maf: a bad influence in the education of macrophages.
Conejo-Garcia JR; Rodriguez PC
J Clin Invest; 2020 Apr; 130(4):1629-1631. PubMed ID: 32175921
[TBL] [Abstract][Full Text] [Related]
4. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages.
Cao S; Liu J; Song L; Ma X
J Immunol; 2005 Mar; 174(6):3484-92. PubMed ID: 15749884
[TBL] [Abstract][Full Text] [Related]
5. Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.
Musick M; Yu X
Immunol Res; 2022 Aug; 70(4):432-440. PubMed ID: 35486115
[TBL] [Abstract][Full Text] [Related]
6. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
Phuengkham H; Ren L; Shin IW; Lim YT
Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696
[TBL] [Abstract][Full Text] [Related]
7. Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance.
Wei F; Wang D; Wei J; Tang N; Tang L; Xiong F; Guo C; Zhou M; Li X; Li G; Xiong W; Zhang S; Zeng Z
Cell Mol Life Sci; 2021 Jan; 78(1):173-193. PubMed ID: 32654036
[TBL] [Abstract][Full Text] [Related]
8. Significance of regulatory T cells in cancer immunology and immunotherapy.
Sugiyama D; Hinohara K; Nishikawa H
Exp Dermatol; 2023 Mar; 32(3):256-263. PubMed ID: 36458459
[TBL] [Abstract][Full Text] [Related]
9. The protozoan parasite Theileria annulata alters the differentiation state of the infected macrophage and suppresses musculoaponeurotic fibrosarcoma oncogene (MAF) transcription factors.
Jensen K; Makins GD; Kaliszewska A; Hulme MJ; Paxton E; Glass EJ
Int J Parasitol; 2009 Aug; 39(10):1099-108. PubMed ID: 19303416
[TBL] [Abstract][Full Text] [Related]
10. The circadian rhythm key gene
Wu G; Ren H; Hu Q; Ma H; Chen H; Zhou L; Xu K; Ding L
Front Immunol; 2023; 14():1115809. PubMed ID: 37275880
[TBL] [Abstract][Full Text] [Related]
11. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
12. The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.
Buoncervello M; Gabriele L; Toschi E
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484464
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness.
Barnestein R; Galland L; Kalfeist L; Ghiringhelli F; Ladoire S; Limagne E
Oncoimmunology; 2022; 11(1):2120676. PubMed ID: 36117524
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
[TBL] [Abstract][Full Text] [Related]
15. Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy.
Jin Z; Sun X; Wang Y; Zhou C; Yang H; Zhou S
Front Immunol; 2022; 13():1018903. PubMed ID: 36300110
[TBL] [Abstract][Full Text] [Related]
16. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
[TBL] [Abstract][Full Text] [Related]
17. Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice.
Yang H; Ko K; Xia M; Li TW; Oh P; Li J; Lu SC
Hepatology; 2010 Apr; 51(4):1291-301. PubMed ID: 20146260
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
19. Target tumor microenvironment by innate T cells.
Li YR; Wilson M; Yang L
Front Immunol; 2022; 13():999549. PubMed ID: 36275727
[TBL] [Abstract][Full Text] [Related]
20. c-Maf regulates the plasticity of group 3 innate lymphoid cells by restraining the type 1 program.
Parker ME; Barrera A; Wheaton JD; Zuberbuehler MK; Allan DSJ; Carlyle JR; Reddy TE; Ciofani M
J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31570496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
